Picture of Werewolf Therapeutics logo

HOWL Werewolf Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Werewolf Therapeutics To Present Preclinical Data On Indukine Molecules At 63rd American Society Of Hematology Annual Meeting

Dec 1 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS TO PRESENT PRECLINICAL DATA ON
INDUKINE™
MOLECULES AT 63RD AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL
MEETING

Source text for Eikon:  ID:nGNX53rDCq 
Further company coverage:  HOWL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Werewolf Therapeutics

See all news